Clinical Scenario by Dr.Vileesh Valsalan

Dr Vilesh Valsalan
Academic Co-ordinator
Dr Vilesh Valsalan is the senior consultant Nephrologist at Specialist hospital and Samaritan hospital Kochi and supervise peripheral dialysis centres around Kochi.He completed his master’s in nephrology from the prestigious Jaslok hospital and research centre , Mumbai.His areas of interest are acute kidney injury, electrolyte disorders and renal transplantation.He is the academic coordinator for ECNG and also runs the monthly dialysis technician knowledge upgradation program.
2729.07.2025ATHEROEMBOLIC RENAL DISEASE [AERD] DOWNLOAD PDF
SI No. | DATE | TOPIC | PDF |
1 | 03.01.2025 | DESIDUSTAT | |
2 | 06.01.2025 | FIBROMUSCULAR DYSPLASIA | |
3 | 17.01.2025 | GLP1 AGONIST | |
4 | 24.01.2025 | PROXYSMAL NOCTURNAL HEMOGLOBINURIA | |
5 | 31.01.2025 | CALCIPHYLAXIS | |
6 | 07.02.2025 | FIBROBLAST GROWTH FACTOR -23 | |
7 | 14.02.2025 | POST TRANSPLANT FSGS RECURRENCE | |
8 | 21.02.2025 | PREIMPLANTATION BIOPSY- DECEASED DONOR TRANSPLANTATION | |
9 | 28.02.2025 | OXALATE NEPHROPATHY | |
10 | 07.03.2025 | FOUR PILLARS-IN THE TREATMENT OF DIABETIC NEPHROPATHY | |
11 | 14.03.2025 | POCUS POINT OF CARE ULTRASONOGRAPHY IN NEPHROLOGY | |
12 | 28.03.2026 | PERI & POST OPERATIVE EVALUATION AND MANAGEMENT OF ATYPICAL HEMOLYTIC UREMIA SYNDROME IN KIDNEY TRANSPLANTATION | |
13 | 18.04.2025 | ADENOVIRUS NEPHROPATHY | |
14 | 26.04.2025 | DONOR SPECIFIC ANTIBODIES (DSA) | |
15 | 02.05.2025 | NONSTONE TRIAL | |
16 | 09.05.2025 | ESA HYPORESPONSIVENESS | |
17 | 23.05.2025 | PROTON PUMP INHIBITORS (PPI) AND KIDNEYS | |
18 | 30.05.2025 | NEWER ANTIBIOTIC PLAZOMICIN | |
19 | 13.06.2025 | ANTICOAGULATION IN CKD | |
20 | 20.06.2025 | TYPE 4 RTA IN DIABETES MELLITUS | |
21 | 27.06.2025 | CAR-T CELL THERAPY AND AKI | |
22 | 11.07.2026 | PREGNANCY -AKI(PRAKI) | |
23 | 18.07.2025 | RENAL ABSCESS | |
24 | 21.03.2025 | EMPHYSEMATOUS PYELONEPHRITIS | |
25 | 25.7.2025 | VASCULAR CALCIFICATION [VC] | |
26 | 29.07.2025 | INDICATIONS FOR THE OPERATIVE MANAGEMENT OF ARAS | |
27 | 29.08.2025 | DARATUMUMAB |